Yearth Obtaining NCCL EQA Certificate
Yearth’s service laboratory in Changsha has obtained the newest EQA Certificate of the National Center for Clinical Laboratories (NCCL). Structural chromosome abnormalities, fetal chromosomal...
View ArticleYearth Obtaining NCCL Certificate for HLA Genotyping
Yearth’s service laboratory in Changsha has obtained the newest EQA Certificate of the National Center for Clinical Laboratories (NCCL). Human Leukocyte Antigen (HLA) A, B, C, DQB1 and DRB1 loci using...
View ArticleResults for Upper Tract Urinary Carcinoma Publish in Cancers
Yearth and the professor, Long Wan in The Third Xiangya Hospital, Central South University, completed the study for auxiliary diagnosis of upper tract urinary carcinoma. The results have been published...
View ArticleYearth Medical Laboratory has achieved ASHI certification, providing HLA...
We are pleased to announce that Yearth Medical Laboratory officially obtained ASHI certification on January 1, 2024. ASHI certification is a recognition of the hard work of our professional team and...
View ArticleYearth Research on Urinary Biopsy Risk Stratification Model Published in...
Yearth and Professor, Long Wang in The Third Xiangya Hospital, Central South University, has developed a new urine biopsy-based risk stratification model. This model identifies residual tumors after...
View ArticleTBG (Xiamen) Selected as a National Reference Laboratory for HLA Typing
Great news! TBG (Xiamen) has been selected as a National Reference Laboratory for Human Leukocyte Antigen (HLA) Typing. The company will actively participate in the HLA-A, HLA-B, HLA-C, HLA-DRB1, and...
View ArticleHLA TGS Kits Results Published in Journal of Clinical Transfusion and...
We are pleased to announce that the clinical results of our HLA TGS kits developed by U-GEN’s subsidiary TBG (Xiamen), titled “Application of ONT in Ambiguous Results of the HLA-DPB1 Genotyping,” have...
View Article